Featured Stories
New Clinical Trial in MDR-TB Care to Support Hardest to Treat Patients Globally
Q&A with Dr. Carole Mitnick, PIH’s co-principal investigator of endTB project Tuberculosis is the most deadly infectious disease, killing more than 1.4 million people globally, most of them in resource-poor countries. Some forms of the disease are resistant to treatment and therefore can’t be cured using standard drugs. These multidrug Read more…